Viewpoints: Age Limits Shouldn’t Block Access To Breakthrough Drugs; Good Riddance To Illegal NIH Funding Cuts
Editorial writers discuss these public health issues.
For most of my life, my family has been advocating for therapies to help my twin brother. While the recent approval of a new drug should give us reason to celebrate, there is still more work to do. (Nathan Grant, 4/14)
The Trump administration quietly conceded defeat last week on its misguided push to slash research funding from the National Institutes of Health. That’s a relief to researchers, but all Americans benefit from the basic and applied research that would have been disrupted by permanent cuts. (4/13)
Amid a dangerous upswing in vaccine disinformation, exacerbated by the anti-vaccine rhetoric of US Health and Human Services secretary Robert F. Kennedy Jr., parents are increasingly turning to nonmedical exemptions to avoid vaccinating their children. (John Snyder, 4/12)
When you’ve got a bad toothache and there’s no immediate relief available, you need something to take your mind off the pain. The Competition and Markets Authority’s study into the supply of private dental services in the UK has the look of a distraction. (Matthew Brooker, 4/14)
Last month, Utah passed a law to increase the amount of raw milk producers can sell and ease testing requirements. Legislatures in Iowa, Oklahoma and Michigan are considering similar bills to expand access to these products. (Leana S. Wen, 4/14)
